PATENT CLAIM ANALYSIS

Application Number: 15756366
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["514", "322000"]

Abstract:
The invention relates to antibacterial compounds of formula I wherein M is one of the groups M A , M B  and M C  represented below wherein R 1 , M A , M B  and M C  are as defined in the specification;and to salts thereof.

Claim (Index 4):
A compound of formula I according to  claim 3 , wherein M is the group M A  wherein R 1A  represents hydrogen or fluorine and R 3A  represents 3-fluoro-1-methyl-azetidin-3-yl, 3-fluoro-1-(oxetan-3-yl)azetidin-3-yl, (3-fluoroazetidin-1-yl)methyl, (3-hydroxyazetidin-1-yl)methyl, (4-hydroxy-3-fluoropiperidin-1-yl)methyl, (4-hydroxy-3,3-difluoropiperidin-1-yl)methyl, (6-amino-3-azabicyclo[3.1.0]hexan-3-yl)methyl, (2-oxa-6-azaspiro[3.3]heptan-6-yl)methyl, 2-(methylsulfonyl)ethoxy, (3-hydroxyazetidin-1-yl)carbonyloxymethyl, (4-methylpiperazin-1-yl)carbonyloxymethyl, N-(2-hydroxyethyl)-N-(methyl)carbamoyloxymethyl or azetidin-3-yloxycarbonylaminomethyl;\n or a salt of this compound.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 88.0
- Lexical Diversity: 1.51515
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15123184', '15021649', '15311758', '15106790', '15751596']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8309066129025657
- 35 USC 102 Novelty (BERT): 0.6448890752608651
- Combined Prediction Score: 0.8123048591383957
- Mean Citation Score: 564.289124
- Max Citation Score: 663.8811599999998
- Similarity Product: 552.5894475598167

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test